GVK Biosciences along with Wyeth Research wins European Outsourcing Award 2009

GVK Biosciences (GVK BIO) a Contract research organization, along with Wyeth Research won the prestigious European Outsourcing Award 2009 for the Best New Partnership. The award was received by Manni Kantipudi, President, GVK BIO at a ceremony held at the Intercontinental Grand, Madrid, on 14th October. GVK BIO-Wyeth came out as winners amongst several competing entries.

Earlier in the year, GVK BIO (Leading Indian CRO's) had filed its nominations under two categories "Best New Product" and the "Best New Partnership/Acquisition/Merger". GVK BIO's entry for the "Best New Product" was its innovative "Clinical Biomarker Database" developed together with a Big Pharma and the US FDA. "GVK BIO - Wyeth: Value co-creators" was GVK BIO's nomination for the "Best New Partnership". A pioneer in Indian discovery services and clinical research services, GVK BIO was declared finalists in both categories.

"We are delighted to have won the Best New Partnership Award along with our partner, Wyeth Research. This award is recognition of the dedication and commitment of our employees in understanding and delivering to our customers' expectations. We are proud that we have been considered alongside with Wyeth and thank them for their faith and commitment to this collaboration" said Manni Kantipudi, President, GVK Biosciences.

The nomination for the Best New Partnership was put together by GVK BIO and Wyeth. It covered the GVK BIO-Wyeth trendsetting deal of 150 synthetic chemistry deal in 2006, further expansion of the collaboration to chemoinformatics and modeling. In 2008, Wyeth and GVK BIO entered into a collaboration based on a risk sharing model to identify and optimize lead series.